The Pharma Data
MAY 15, 2021
Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. Click here to get The Longevity Breakthrough Your Doctor Won't Tell You About at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.
XTalks
JUNE 3, 2021
Therefore, eating an apple a day may in fact keep the doctor away. The study , published yesterday in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism , revealed that two helpings of fruit led to higher measures of insulin sensitivity than those who ate less than half a serving. Keep it Fresh.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JANUARY 28, 2021
As we’ve seen over those five years, biosimilars are critical in continuing to provide doctors and patients choice in their care plans as well as continuing to decrease overall healthcare costs. One of these markets is the insulin market. Americans pay ten times as much for insulin as Canadian patients do.
The Pharma Data
AUGUST 17, 2021
approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.
Pharmaceutical Technology
AUGUST 31, 2022
Alongside fitness trackers and smartwatches, there are also medical devices used to monitor a patient’s vitals and some even contain SIM cards to enable two-way communication.
The Pharma Data
MAY 14, 2021
Description: In this 8 Episode Diabetes-Fighting Series, I get to meet several doctors, nutritionists, current and former diabetics, from the around the world. Every companion guide contains a summary of the core concepts of the corresponding episode. I met up with dozens of doctors, nutritionists and other experts.
XTalks
NOVEMBER 9, 2022
GLP-1 receptor agonists, or incretin (metabolic hormones) mimetics, are analogs of the GLP-1 peptide hormone that binds to the GLP-1 receptor to regulate blood sugar levels by boosting insulin secretion. dependent insulin secretion and suppression of glucagon release. mediated glucose?dependent Active Ingredient(s).
Expert insights. Personalized for you.
52 
Let's personalize your content